Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Multicenter evaluation of analytical characteristics of the Elecsys® Periostin immunoassay.

Palme S, Christenson RH, Jortani SA, Ostlund RE, Kolm R, Kopal G, Laubender RP.

Clin Biochem. 2017 Feb;50(3):139-144. doi: 10.1016/j.clinbiochem.2016.10.002. Epub 2016 Oct 8.


Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P-Glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP).

Schwarz T, Montanari F, Cseke A, Wlcek K, Visvader L, Palme S, Chiba P, Kuchler K, Urban E, Ecker GF.

ChemMedChem. 2016 Jun 20;11(12):1380-94. doi: 10.1002/cmdc.201500592. Epub 2016 Mar 10.


Deconstruction of a nutlin: dissecting the binding determinants of a potent protein-protein interaction inhibitor.

Fry DC, Wartchow C, Graves B, Janson C, Lukacs C, Kammlott U, Belunis C, Palme S, Klein C, Vu B.

ACS Med Chem Lett. 2013 May 24;4(7):660-5. doi: 10.1021/ml400062c. eCollection 2013 Jul 11.


Towards a comprehensive proteome of normal and malignant human colon tissue by 2-D-LC-ESI-MS and 2-DE proteomics and identification of S100A12 as potential cancer biomarker.

Thierolf M, Hagmann ML, Pfeffer M, Berntenis N, Wild N, Roeßler M, Palme S, Karl J, Bodenmüller H, Rüschoff J, Rossol S, Rohr G, Rösch W, Friess H, Eickhoff A, Jauch KW, Langen H, Zolg W, Tacke M.

Proteomics Clin Appl. 2008 Jan;2(1):11-22. doi: 10.1002/prca.200780046. Epub 2007 Dec 11. No abstract available.


Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.

Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, Engel AM, Pfeffer M, Karl J, Bodenmüller H, Rüschoff J, Henkel T, Rohr G, Rossol S, Rösch W, Langen H, Zolg W, Tacke M.

Mol Cell Proteomics. 2006 Nov;5(11):2092-101. Epub 2006 Aug 6.


Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column.

Brand J, Haslberger T, Zolg W, Pestlin G, Palme S.

Proteomics. 2006 Jun;6(11):3236-42.


Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.

Roessler M, Rollinger W, Palme S, Hagmann ML, Berndt P, Engel AM, Schneidinger B, Pfeffer M, Andres H, Karl J, Bodenmüller H, Rüschoff J, Henkel T, Rohr G, Rossol S, Rösch W, Langen H, Zolg W, Tacke M.

Clin Cancer Res. 2005 Sep 15;11(18):6550-7.


Composition and analysis of liquid smoke flavouring primary products.

Simon R, de la Calle B, Palme S, Meier D, Anklam E.

J Sep Sci. 2005 Jun;28(9-10):871-82.


NMR structure of a complex between MDM2 and a small molecule inhibitor.

Fry DC, Emerson SD, Palme S, Vu BT, Liu CM, Podlaski F.

J Biomol NMR. 2004 Oct;30(2):163-73.


Development of enzyme-immunoassays based on egg yolk antibodies for the detection of mycotoxins.

Pichler H, Baumgartner S, Freudenschuss M, Palme S, Binder E, Krska R.

Mycotoxin Res. 2001 Jun;17 Suppl 2:202-5. doi: 10.1007/BF03036436.


The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.

Stoll R, Renner C, Zweckstetter M, Brüggert M, Ambrosius D, Palme S, Engh RA, Golob M, Breibach I, Buettner R, Voelter W, Holak TA, Bosserhoff AK.

EMBO J. 2001 Feb 1;20(3):340-9.


Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53.

Stoll R, Renner C, Hansen S, Palme S, Klein C, Belling A, Zeslawski W, Kamionka M, Rehm T, Mühlhahn P, Schumacher R, Hesse F, Kaluza B, Voelter W, Engh RA, Holak TA.

Biochemistry. 2001 Jan 16;40(2):336-44.


Unusual domain pairing in a mutant of bovine lens gammaB-crystallin.

Palme S, Jaenicke R, Slingsby C.

J Mol Biol. 1998 Jun 26;279(5):1053-9.


X-ray structures of three interface mutants of gammaB-crystallin from bovine eye lens.

Palme S, Jaenicke R, Slingsby C.

Protein Sci. 1998 Mar;7(3):611-8.


Supplemental Content

Support Center